Why choose Redica Systems for Inspection Preparation?

Easily prepare for your inspector’s tendencies and hot-button items.

In this demo you will dive into:

  • Investigator profiles
  • Inspection outcomes mapped to quality system 
  • Inspection types
  • Industry Trends mapped to GxP quality system
  • Peer benchmarks
Chosen by global leaders and innovators
Medtronic 1
seagen 1
Fresenius 2

Get a comprehensive view

In-depth Investigator Profiles

With more than 4,500 distinct FDA Investigator Profiles containing data from proprietary research and quality-system classification, you’ll easily see how to prepare for your inspector’s tendencies and hot-button items.

Investigator Prep

Unlock insights. Be better prepared.

Enforcement Analytics includes data sets such as:
Pre-approval inspection (PAI) trends

Understand latest trends for 483 Observations on PAIs inspections – for Human Drugs, Biologics, and Medical Devices.

Internal audit and inspection planning

Base your audits and inspection planning activity on the most comprehensive and up-to-date inspection and enforcement trends and how you benchmark to the industry.

Cross-agency trends

Leverage our cross-agency tables to link citations and non-conformances to your quality system categories.

FDA Investigator Profiles

Get the details you need with the full inspection and citation history for FDA investigators.

Comprehensive Industry Reports

With the largest dataset of FDA 483s, Warning Letters, Health Canada Citations, EMA Critical Deficiencies, and more, you will have the most fact-based trends to power your inspection preparation program.

No longer “in the dark” when it comes to FDA inspection intelligence

Discover how a leading pharmaceutical company uses our data to always be prepared for agency inspections


A global pharmaceutical firm manages 10 FDA regulatory inspections per year across its 100 global sites. They relied on tribal knowledge and consultants for inspection preparation with limited visibility into the latest agency trends and hot-buttons.

They were often caught off-guard by the idiosyncrasies of specific FDA inspectors.

“We need data-driven inspection intelligence. We don’t need anecdotes”



For strategic planning, the client leverages our Annual Observation Trend Report to discover the latest trends in 483 Observations, providing a fact-based way to focus their planning efforts on the top-cited items.

For tactical planning, the client uses our Inspector Profiles to deep-dive into the specifics of each inspector, including their CV, their categorized observations and citation history, and how they benchmark against agency averages.

Asset 10@2x


With access to recent and historic inspection and enforcement trends, plus knowing how inspectors behave, the teams are able to prioritize their inspection prep with precision and confidence.

Inspection Prep Impact@2x